Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc sulfate add-on therapy versus risperidone alone in schizophrenia
IRCT138801241457N3Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing Risperidone + zinc sulfate with Risperidone + placebo (2 arms). Started Mar 2008; status: completed.
02
Drugs
zincrisperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT138801241457N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138801241457N3.